TY - JOUR
T1 - Spinal Infection Secondary to Mycobacterium branderi
AU - Drakopoulos, Michael
AU - Ogbuefi, Nonye
AU - Galvin, Shannon
AU - Kling, Kendall
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Mycobacterium branderi is a rare, slow-growing, nontuberculous mycobacterium initially identified as a species in 1995. Mycobacterium branderi has previously been reported as the sole pathogen isolated from pulmonary cavitary lesions and from a hand infection. We present a case of M. branderi as the sole pathogen isolated from a spinal epidural abscess associated with discitis, osteomyelitis, and psoas muscle abscesses in an immunocompromised host. The isolate was subjected to DNA hybridization testing and 16S rRNA gene sequencing, with results consistent with M. branderi and Mycobacterium celatum. Subsequent RNA polymerase β subunit gene sequencing identified the organism as M. branderi. The spinal infection is being treated with trimethoprim-sulfamethoxazole, ethambutol, azithromycin, and rifabutin. Repeat spinal cultures after initiation of treatment were negative for growth suggesting eradication of the organism.
AB - Mycobacterium branderi is a rare, slow-growing, nontuberculous mycobacterium initially identified as a species in 1995. Mycobacterium branderi has previously been reported as the sole pathogen isolated from pulmonary cavitary lesions and from a hand infection. We present a case of M. branderi as the sole pathogen isolated from a spinal epidural abscess associated with discitis, osteomyelitis, and psoas muscle abscesses in an immunocompromised host. The isolate was subjected to DNA hybridization testing and 16S rRNA gene sequencing, with results consistent with M. branderi and Mycobacterium celatum. Subsequent RNA polymerase β subunit gene sequencing identified the organism as M. branderi. The spinal infection is being treated with trimethoprim-sulfamethoxazole, ethambutol, azithromycin, and rifabutin. Repeat spinal cultures after initiation of treatment were negative for growth suggesting eradication of the organism.
KW - drug susceptibility testing
KW - immunocompromised
KW - Mycobacterium branderi
KW - nontuberculous mycobacterium
KW - spinal abscess
UR - http://www.scopus.com/inward/record.url?scp=85206505349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85206505349&partnerID=8YFLogxK
U2 - 10.1097/IPC.0000000000001193
DO - 10.1097/IPC.0000000000001193
M3 - Article
AN - SCOPUS:85206505349
SN - 1056-9103
VL - 31
JO - Infectious Diseases in Clinical Practice
JF - Infectious Diseases in Clinical Practice
IS - 1
M1 - e1193
ER -